287 related articles for article (PubMed ID: 16624619)
1. Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals.
Montoya CJ; Velilla PA; Chougnet C; Landay AL; Rugeles MT
Clin Immunol; 2006 Aug; 120(2):138-46. PubMed ID: 16624619
[TBL] [Abstract][Full Text] [Related]
2. Altered dendritic cell-natural killer interaction in Kenyan sex workers resistant to HIV-1 infection.
Ghadially H; Keynan Y; Kimani J; Kimani M; Ball TB; Plummer FA; Mandelboim O; Meyers AF
AIDS; 2012 Feb; 26(4):429-36. PubMed ID: 22156969
[TBL] [Abstract][Full Text] [Related]
3. The impaired response of NK cells from HIV-infected progressor patients to A-class CpG oligodeoxynucleotides is largely dependent of a decreased production of IL-12.
Saez R; Echaniz P; De Juan MD; Iribarren JA; Cuadrado E
Immunol Lett; 2007 Mar; 109(1):83-90. PubMed ID: 17343921
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of immunomagnetic methods used for separation of human natural killer cells from peripheral blood.
Øren A; Husebø C; Iversen AC; Austgulen R
J Immunol Methods; 2005 Aug; 303(1-2):1-10. PubMed ID: 16054641
[TBL] [Abstract][Full Text] [Related]
5. IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12.
van de Wetering D; de Paus RA; van Dissel JT; van de Vosse E
Int Immunol; 2009 Feb; 21(2):145-53. PubMed ID: 19088061
[TBL] [Abstract][Full Text] [Related]
6. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns.
Doherty DG; Norris S; Madrigal-Estebas L; McEntee G; Traynor O; Hegarty JE; O'Farrelly C
J Immunol; 1999 Aug; 163(4):2314-21. PubMed ID: 10438977
[TBL] [Abstract][Full Text] [Related]
7. Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.
Mavilio D; Lombardo G; Benjamin J; Kim D; Follman D; Marcenaro E; O'Shea MA; Kinter A; Kovacs C; Moretta A; Fauci AS
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2886-91. PubMed ID: 15699323
[TBL] [Abstract][Full Text] [Related]
8. Induction of interferon-gamma from natural killer cells by immunostimulatory CpG DNA is mediated through plasmacytoid-dendritic-cell-produced interferon-alpha and tumour necrosis factor-alpha.
Marshall JD; Heeke DS; Abbate C; Yee P; Van Nest G
Immunology; 2006 Jan; 117(1):38-46. PubMed ID: 16423039
[TBL] [Abstract][Full Text] [Related]
9. CD8+ NK cells are predominant in chimpanzees, characterized by high NCR expression and cytokine production, and preserved in chronic HIV-1 infection.
Rutjens E; Mazza S; Biassoni R; Koopman G; Ugolotti E; Fogli M; Dubbes R; Costa P; Mingari MC; Greenwood EJ; Moretta L; De Maria A; Heeney JL
Eur J Immunol; 2010 May; 40(5):1440-50. PubMed ID: 20306468
[TBL] [Abstract][Full Text] [Related]
10. Polyfunctional natural killer cells with a low activation profile in response to Toll-like receptor 3 activation in HIV-1-exposed seronegative subjects.
Lima JF; Oliveira LMS; Pereira NZ; Duarte AJS; Sato MN
Sci Rep; 2017 Apr; 7(1):524. PubMed ID: 28373665
[TBL] [Abstract][Full Text] [Related]
11. Profiles of NK, NKT cell activation and cytokine production following vaccination against hepatitis B.
Albarran B; Goncalves L; Salmen S; Borges L; Fields H; Soyano A; Montes H; Berrueta L
APMIS; 2005; 113(7-8):526-35. PubMed ID: 16086823
[TBL] [Abstract][Full Text] [Related]
12. Altered distribution of natural killer cell subsets identified by CD56, CD27 and CD70 in primary and chronic human immunodeficiency virus-1 infection.
Titanji K; Sammicheli S; De Milito A; Mantegani P; Fortis C; Berg L; Kärre K; Travi G; Tassandin C; Lopalco L; Rethi B; Tambussi G; Chiodi F
Immunology; 2008 Feb; 123(2):164-70. PubMed ID: 17627773
[TBL] [Abstract][Full Text] [Related]
13. Impaired function of innate T lymphocytes and NK cells in the acute phase of ischemic stroke.
Peterfalvi A; Molnar T; Banati M; Pusch G; Miko E; Bogar L; Pal J; Szereday L; Illes Z
Cerebrovasc Dis; 2009; 28(5):490-8. PubMed ID: 19752550
[TBL] [Abstract][Full Text] [Related]
14. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
[TBL] [Abstract][Full Text] [Related]
15. The correlation between the percent of CD3- CD56+ cells and NK precursor function.
Gharehbaghian A; Donaldson C; Newman J; Bannister G; Bradley BA
Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):167-75. PubMed ID: 17237569
[TBL] [Abstract][Full Text] [Related]
16. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure.
Golden-Mason L; Madrigal-Estebas L; McGrath E; Conroy MJ; Ryan EJ; Hegarty JE; O'Farrelly C; Doherty DG
Gut; 2008 Aug; 57(8):1121-8. PubMed ID: 18372499
[TBL] [Abstract][Full Text] [Related]
17. Correlation of human CD56+ cell cytotoxicity and IFN-gamma production.
Derby EG; Reddy V; Nelson EL; Kopp WC; Baseler MW; Dawson JR; Malyguine AM
Cytokine; 2001 Jan; 13(2):85-90. PubMed ID: 11145847
[TBL] [Abstract][Full Text] [Related]
18. Large-scale expansion of CD3(+)CD56(+) lymphocytes capable of lysing autologous tumor cells with cytokine-rich supernatants.
Gritzapis AD; Dimitroulopoulos D; Paraskevas E; Baxevanis CN; Papamichail M
Cancer Immunol Immunother; 2002 Oct; 51(8):440-8. PubMed ID: 12202905
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cell subpopulations in putative resistant individuals and patients with active Mycobacterium tuberculosis infection.
Barcelos W; Sathler-Avelar R; Martins-Filho OA; Carvalho BN; Guimarães TM; Miranda SS; Andrade HM; Oliveira MH; Toledo VP
Scand J Immunol; 2008 Jul; 68(1):92-102. PubMed ID: 18484953
[TBL] [Abstract][Full Text] [Related]
20. Function of NKT cells, potential anti-HIV effector cells, are improved by beginning HAART during acute HIV-1 infection.
Vasan S; Poles MA; Horowitz A; Siladji EE; Markowitz M; Tsuji M
Int Immunol; 2007 Aug; 19(8):943-51. PubMed ID: 17702988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
